1887
  1. Home
  2. A-Z Publications
  3. Global Cardiology Science and Practice
  4. Volume 2015, Issue 3
  5. Article
Volume 2015, Issue 3
  • ISSN: 2305-7823
  • EISSN:

Abstract

Although essentially disappeared from the industrialized world, rheumatic heart disease (RHD) is still prevalent in developing countries, with 300,000 new cases identified each year. In Aswan, Egypt, RHD affects about 2.3% of children with over 90% of the cases being subclinical. Secondary prophylaxis has proved to be an effective method of preventing the progression of RHD. However, its efficacy is limited by low patient adherence. A systematic, generalizable tool is necessary to outline, and ultimately address these barriers. A 43-item semi-structured questionnaire was developed based on the three domains outlined by Fishbein (capability, intention, and health care barriers). A preliminary evaluation of the barriers to RHD prophylaxis use in Aswan, Egypt was carried out as a pilot study using this tool. Participants were local school children diagnosed with RHD or flagged as high-risk (as per a set of echocardiographic criteria developed by the Aswan Heart Centre) through a previous screening program of randomly selected 3,062 school children in Aswan. 29 patients were interviewed (65.5% adherent to RHD prophylaxis). Compared to non-adherent patients, adherent patients had better understanding of the disease (68.4% versus 20% in the non-adherent group, p = 0.021), and were more aware of the consequences of missing prophylaxis doses (79% versus 40% of non-adherent patients, p = 0.005). Furthermore, 90% of non-adherent patients consciously choose to miss injection appointments (as compared to 31.6% of adherent patients, p = 0.005). Clinic wait time was the most frequently reported deterrent for both groups. A standardized tool that systematically outlines barriers to prophylaxis is a necessary first step to improving adherence to penicillin. Although individually developed tools exist for specific populations, a generalizable tool that takes into account the demographic and cultural differences in the populations of interest will allow for more reliable data collection methodology. Application of this tool will be used to further explore barriers to prophylaxis adherence and inform the basis for the design of future KT interventions.

© 2010 Balbaa, ElGuindy, Pericak, Yacoub, Schwalm, licensee Bloomsbury Qatar Foundation Journals.
Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2015.40
2015-10-17
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2015/3/gcsp.2015.40.html?itemId=/content/journals/10.5339/gcsp.2015.40&mimeType=html&fmt=ahah

References

  1. Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM, World Heart Federation . Position Statement of the World Heart Federation on the Prevention and Control of Rheumatic Heart Disease. Nature reviews. Cardiology. 2013; 10:5:284–292.
     [Google Scholar]
  2. Edmund A, Patrick J. Rheumatic Fever and Valvular Heart Disease. Essential Cardiology. 2006; 3::545–563.
     [Google Scholar]
  3. McDonald M, Brown A, Noonan S, Carapetis JR. Preventing Recurrent Rheumatic Fever: The Role of Register Based Programmes. Heart (British Cardiac Society). 2005; 91:9:1131–1133.
     [Google Scholar]
  4. Musoke Charles, Mondo Charles Kiiza, Zhang Wanzhu, Freers Juergen, Okello Emmy, Kakande Barbara, Nyakoojo Wilson. Benzathine Penicillin Adherence for Secondary Prophylaxis Among Patients Affected with Rheumatic Heart Disease Attending Mulago Hospital: Cardiovascular Topics. Cardiovascular Journal Of Africa. 2013; 24:4:124–129.
     [Google Scholar]
  5. Eisenberg MJ. Rheumatic Heart Disease in the Developing World: Prevalence, Prevention, and Control. European Heart Journal. 1993; 14:1:122–128.
     [Google Scholar]
  6. Silverman Stuart L, Maricic Michael. Recent Developments in Bisphosphonate Therapy. Seminars in arthritis and rheumatism. 2007; 37:1:1–12.
     [Google Scholar]
  7. Hassel T, Renwick S, Stuart K. Rheumatic Fever and Rheumatic Heart Disease in Barbados: Detection and Prophylaxis. British Medical Journal. 1972;5823–3.
     [Google Scholar]
  8. Gasse B, Baroux N, Rouchon B, Meunier J-M, De Fremicourt I, D'Ortenzio E. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study. BMC Public Health. 2013.
     [Google Scholar]
  9. Barreira JL, Baptista MJ, Moreira J, Azevedo A, Areias JC. Understanding of endocarditis risk improves compliance with prophylaxis. Rev Port Cardiol. 2002;939–951.
     [Google Scholar]
  10. Hassell TA, Renwick S, Stuart KL. Rheumatic Fever and Rheumatic Heart Disease in Barbados: Detection and Prophylaxis. British Medical Journal. 1972; 3:5823:387–9.
     [Google Scholar]
  11. Yacoub M, Kotit S. An Echocardiographic Screening of School Children for Rheumatic Heart Disease in Aswan, Egypt. Qatar Foundation Annual Research Forum Proceedings. 2012.
     [Google Scholar]
  12. Penn C, Watermeyer J, Evans M. Why don't patients take their drugs? The role of communication, context and culture in patient adherence and the work of the pharmacist in HIV/AIDS. Patient Education and Counseling. 2011; 83:3:310–18.
     [Google Scholar]
  13. Fishbein M, Cappella J. The Role of Theory in Developing Effective Health Communications. Journal of Communication. 2006.
     [Google Scholar]
  14. Central Agency for Public Mobilization and Statistics. Available at: http://www.capmas.gov.eg/?lang=2. Accessed 21 December 2015.
  15. Lee JW, Jones PS, Mineyama Y, Zhang XE. Cultural differences in responses to a Likert scale. Res Nurs Health. 2002; 25:4:295–306.
     [Google Scholar]
  16. Van Laerhoven H, Van Der Zaag-Loonen HJ, Derkx BH. A comparison of Likert scale and visual analogue scales as response options in children's questionnaires. Acta Paediatrica. 2004; 93:6:830–835.
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2015.40
Loading
An evaluation of secondary prophylaxis for rheumatic heart disease in rural Egypt
Global Cardiology Science and Practice 2015, 40 (2015); https://doi.org/10.5339/gcsp.2015.40
/content/journals/10.5339/gcsp.2015.40
/content/journals/10.5339/gcsp.2015.40
Loading

Data & Media loading...

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error